ONCT - Oncternal Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ONCT (1260990)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-02-23
ONCTHale David FDirP - Purchase$9.04+98031,304+3%+$8,859
2024-02-23
ONCTWills Robert JamesDirS - Sale$9.04-9800-100%-$8,859
M
2023-06-12
ONCTKaufmann Gunnar F.Chief Scientific OfficerP - Purchase$0.35+28,00094,726+42%+$9,824
M
2023-04-13
ONCTBreitmeyer James BCEOP - Purchase$0.29+150,000763,176+24%+$43,930
M
2023-04-12
ONCTYazji SalimChief Medical OfficerP - Purchase$0.29+25,000164,676+18%+$7,200
M
2023-04-12
ONCTLeavitt Chase C.GC, SecretaryP - Purchase$0.29+25,000106,901+31%+$7,250
2023-04-13
ONCTVincent Richard GCFOP - Purchase$0.30+30,000163,219+23%+$8,961

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top